Dr. Schwab is Associate Professor of Orthopaedic surgery at Harvard Medical School and the Chief of Spine Surgery at Massachusetts General Hospital. He is the director of Spine Oncology and the Co-Director of the Stephen Harris Chordoma Center at Massachusetts General Hospital.
He studied religion at Miami University before attending Chicago Medical School where he graduated with honors and he was a member of Alpha Omega Alpha honor society
concurrently earning a Master’s degree in pathology. While at the Mayo Clinic, where he received his orthopaedic training, he was awarded the Patrick Kelly Award for outstanding orthopaedic research for his work on the IGF pathway in neo-chondrogenesis. Dr. Schwab spent two further years of training at Memorial Sloan Kettering Cancer Center focusing on orthopaedic oncology before spending one year as a spine fellow at the Hospital for Special Surgery. He was awarded the Richard A Brand Award from the Orthopaedic Research Society in 2017 for his work on HLA Class 1 Antigen Expression in giant cell tumors. Dr. Schwab’s clinical interest include degenerative, infectious, oncologic and traumatic conditions of the spine. His clinical research interests mirror his clinical practice where his group is utilizing machine learning techniques to predict outcomes in patients. They have developed and validated several models including prediction of survival in chondrosarcoma, spinal metastases and extremity metastases. Furthermore, they have developed models that predict which patients are at high risk for prolonged opiate usage after elective spinal surgery, and which patients are likely to be discharged from the hospital to a nursing home or rehabilitation center as opposed to home.